1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > PRESCRIPTION PAIN DRUGS–INCLUDING OPIOID, ANTICONVULSANT, INJECTABLE/INHALED, TOPICAL/TRANSDERMAL, MEDICAL MARIJUANA–GLOBAL MARKETS, COMPETITORS AND OPPORTUNITIES: 2015-2020 ANALYSIS AND FORECASTS

PRESCRIPTION PAIN DRUGS–INCLUDING OPIOID, ANTICONVULSANT, INJECTABLE/INHALED, TOPICAL/TRANSDERMAL, MEDICAL MARIJUANA–GLOBAL MARKETS, COMPETITORS AND OPPORTUNITIES: 2015-2020 ANALYSIS AND FORECASTS

  • September 2015
  • -
  • Amadee and Company
  • -
  • 283 pages

Summary

Table of Contents

Search Inside

Abstract

Pain is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage. At some point, everyone experiences pain. Pain may be described according to severity (mild, moderate, severe), duration (acute or chronic) or type (nociceptive, inflammatory, neuropathic).

Mild-to-moderate pain, such as orthopedic and soft tissue-related pain, generally is treated with NSAIDs, celecoxib (Pfizer’s Celebrex), or mild opioid analgesics, such as tramadol. Moderate-to-moderately severe pain, such as post-operative pain, orthopedic pain, and chronic back pain, generally is treated with opioid analgesics, including short-acting opioids such as hydrocodone, oxycodone, oxymorphone, and morphine, as well as extended-release formulations of oxycodone, oxymorphone, and morphine. Severe pain, including post-operative and cancer pain, generally is treated with fentanyl products, such as Duragesic, Actiq, and Fentora, as well as morphine formulations, such as Avinza and Kadian.

This report deals with prescription drugs used to treat pain. While the Prescription Pain Drug market is relatively small and very mature, there are many new products coming online that have significant sales potential including Pfizer’s Remoxy, Oxycodone NT and Embeda drugs, AcelRx’s Zlaviso, Eagalet Corp’s Oxayado, Endo/BDSI’s Buprenorphine, GW Pharmaceuticals’ Sativex, Insys’ Subsys and dronabinol OS, Marinus’ ganaxolone, as well as Bedrocan’s and Tweed’s medical marijuana offerings, among others.

Ultimately however, Prescription Pain Drugs are very important because without them life would be intolerable for millions of people.

For example, an estimated 50% of cancer patients experience some form of pain, which increases to 90% for patients with advanced-stage disease. Even worse, as many as 50% of patients may be under-treated for cancer-associated pain.

This report provides:

- In-depth discussion of Pain Pharmacology and Analgesia.
- Overview of the Prescription Pain Drugs market by product class, applications, producer market shares, market drivers and R&D pipelines.
- Comprehensive analysis of the markets for Opioid, Neuropathic, Injectable/Inhaled, Topical/Transdermal and Medical Marijuana drugs used to treat pain.

Additionally, detailed profiles of 32 leading companies involved in the Prescription Pain Drugs industry are given. The report also includes 46 tables and 30 figures.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Acute Stress Disorder Global Clinical Trials Review, H1, 2017

Acute Stress Disorder Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • March 2017
  • by GlobalData

Acute Stress Disorder Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acute Stress Disorder Global Clinical Trials Review, H1, 2017" provides an overview of Acute ...

Acute Pain Global Clinical Trials Review, H1, 2017

Acute Pain Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • February 2017
  • by GlobalData

Acute Pain Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acute Pain Global Clinical Trials Review, H1, 2017” provides an overview of Acute Pain clinical trials ...

Tramadol / Acetaminophen Sales, Price Analysis, & Sales Forecast - 2017

Tramadol / Acetaminophen Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Tramadol / Acetaminophen Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Tramadol / Acetaminophen worldwide and by countries in North ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • April 2017
    44 pages
  • Therapy  

    Serotonin Speci...  

    Antidepressant  

  • United States  

View report >

Stroke Statistics in the US

  • April 2017
    4 pages
  • Stroke  

    Blood Disease  

  • United States  

View report >

Opioid Market and Digestive System Disorder Statistics in the US

  • April 2017
    20 pages
  • Opioid  

    Digestive Syste...  

  • United States  

View report >

Related Market Segments :

Opioid
Analgesic
Pharmaceutical
Marijuana

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.